Previous Article | Next Article ![]()
Mol. Cell. Biol., 11 1995, 6443-6453, Vol 15, No. 11
R Khosravi-Far, PA Solski, GJ Clark, MS Kinch and CJ Der
Although substantial evidence supports a critical role for the activation
of Raf-1 and mitogen-activated protein kinases (MAPKs) in oncogenic
Ras-mediated transformation, recent evidence suggests that Ras may activate
a second signaling pathway which involves the Ras- related proteins Rac1
and RhoA. Consequently, we used three complementary approaches to determine
the contribution of Rac1 and RhoA function to oncogenic Ras-mediated
transformation. First, whereas constitutively activated mutants of Rac1 and
RhoA showed very weak transforming activity when transfected alone, their
coexpression with a weakly transforming Raf-1 mutant caused a greater than
35-fold enhancement of transforming activity. Second, we observed that
coexpression of dominant negative mutants of Rac1 and RhoA reduced
oncogenic Ras transforming activity. Third, activated Rac1 and RhoA further
enhanced oncogenic Ras-triggered morphologic transformation, as well as
growth in soft agar and cell motility. Finally, we also observed that
kinase-deficient MAPKs inhibited Ras transformation. Taken together, these
data support the possibility that oncogenic Ras activation of Rac1 and
RhoA, coupled with activation of the Raf/MAPK pathway, is required to
trigger the full morphogenic and mitogenic consequences of oncogenic Ras
transformation.
Copyright © 1995, American Society for Microbiology
Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation
Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill 27599, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»